Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Probiotic Supplementation During Pregnancy on Maternal and Infant Outcomes in Preeclampsia High-risk Groups Based on Abnormal Intestinal Flora: a Randomized Controlled Clinical Trial

NCT05554185 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT05554185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Probiotic Supplementation During Pregnancy on Maternal and Infant Outcomes in Preeclampsia High-risk Groups Based on Abnormal Intestinal Flora: a Randomized Controlled Clinical Trial
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
September 21, 2022
Completion date
December 31, 2024
Enrollment
338 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pe (pre-eclampsia) high-risk population with gut microbiota dysbiosis during their pregnancy